INHA rs2300602: Understanding This Common Genetic Variant
The rs2300602 variant is a common genetic change located within the INHA gene, which provides instructions for making a protein involved in reproductive health. While this variant was once studied as a potential factor in reproductive conditions, it is now widely classified as a benign, common variation found in healthy individuals.
What each genotype means
Typical ovarian function profile
You carry two copies of the common G allele in the INHA gene. This genotype represents the baseline reference sequence observed in most populations and has not been associated with altered inhibin alpha signaling. Research indicates you have a typical baseline risk profile for premature ovarian insufficiency related to this variant.
Carried by over 98% of people worldwide, including more than 99% of individuals of European ancestry.
Uncertain ovarian risk variant
You carry one copy of the A allele (historically reported as c.769G>A or p.Ala257Thr) in the INHA gene. While earlier candidate-gene studies proposed this missense change as a cause of premature ovarian insufficiency, modern clinical guidelines classify it as benign or of uncertain clinical significance because it is commonly identified in fertile, healthy individuals. Carrying this variant does not indicate a diagnosis of ovarian insufficiency or impaired fertility.
Carried by approximately 1 to 2 in 100 people of South Asian and Middle Eastern descent, and fewer than 1 in 100 individuals of European ancestry.
Homozygous uncertain ovarian variant
You carry two copies of the A allele in the INHA gene. Although historically linked to diminished ovarian reserve and premature ovarian failure in early literature, contemporary population sequencing demonstrates that this variant does not consistently cause reproductive disorders. The clinical evidence supporting a harmful effect is weak and conflicting, and current classifications view it as a benign or uncertain variant rather than a pathogenic mutation.
Very rare across all ancestries, occurring in fewer than 1 in 10,000 individuals globally.
What is rs2300602 and Where is it Located?
The rs2300602 variant is a single nucleotide polymorphism (SNP) located within the INHA gene. In genetics, a SNP represents a variation at a single position in the DNA sequence among individuals. The INHA gene is situated on chromosome 2 at position 2q35. Because this variant is a common feature of the human genome, it is frequently identified during routine genetic testing or large-scale genomic sequencing projects. It is important to understand that the presence of a variant does not inherently imply a health concern; rather, it is simply a point of natural genetic diversity that distinguishes one person's DNA from another's.
The Role of the INHA Gene
The INHA gene encodes the inhibin alpha subunit, a protein that belongs to the transforming growth factor-beta (TGF-beta) superfamily. Inhibins are complex proteins that play a critical role in the endocrine system, particularly in the regulation of reproductive processes. By interacting with other subunits, the inhibin alpha protein helps modulate the production of follicle-stimulating hormone (FSH), which is essential for the development of eggs in females and sperm in males. Because of its central role in these pathways, researchers have historically investigated the INHA gene to see if specific variations might contribute to reproductive disorders, such as premature ovarian insufficiency (POI).
Research and Clinical Significance
In the past, researchers hypothesized that certain variants in the INHA gene might be linked to reproductive health challenges. However, as more data has been collected from large, diverse populations, the scientific consensus regarding rs2300602 has shifted. Current evidence indicates that this variant is frequently observed in healthy, fertile individuals, leading experts to classify it as benign. It is no longer considered a primary cause of reproductive conditions like premature ovarian insufficiency. While the gene itself remains a subject of interest in reproductive biology and oncology, this specific variant is widely regarded as a normal part of human genetic variation rather than a marker for disease.
Population Frequency
The rs2300602 variant is considered common across many global populations. Genetic databases indicate that this variant appears at a high frequency, meaning that a significant portion of the general population carries one or more copies of the variant allele. Because it is so prevalent in healthy individuals, it serves as a clear example of how common genetic variations are often unrelated to clinical health outcomes.
What This Information Means for You
If you have received a report identifying the rs2300602 variant, it is important to view this information in the context of its benign classification. Because this variant is common and not associated with disease, it generally does not require clinical follow-up or medical intervention. Genetic information can be complex, and it is always best to discuss any findings from genetic tests with a qualified healthcare provider or a genetic counselor. They can help you interpret your results accurately and provide guidance based on your personal and family health history. Never use genetic data to make independent medical decisions or to diagnose yourself with a condition.
How common is this variant?
The rs2300602 variant is common across many global populations, appearing frequently in healthy individuals regardless of ancestry.
Frequently asked questions
Is rs2300602 a cause of infertility?
No, current scientific consensus classifies rs2300602 as a benign variant. It is frequently found in healthy, fertile individuals and is not considered a cause of infertility.
Should I be worried if I have this variant?
There is no reason for concern. This variant is a common, normal part of human genetic diversity and is not linked to any specific health conditions.
Does this variant affect my risk of ovarian cancer?
While the INHA gene is involved in reproductive pathways, rs2300602 is not established as a risk factor for ovarian cancer. It is classified as a benign variant.
Do I need to see a doctor about this result?
Generally, no. Because this variant is benign and common, it does not typically require medical follow-up. However, you can always discuss any genetic test results with your doctor for peace of mind.
Sources & further reading
Educational information only, last refreshed 10/16/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs2300602?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29